Elevated resting heart rate is an independent predictor of all-cause death and cardiovascular events in Japanese ambulatory hemodialysis patients

Center of Residency and Fellowship Program, Faculty of Medicine, University Hospital of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan, .
Clinical and Experimental Nephrology (Impact Factor: 2.02). 05/2012; 16(6). DOI: 10.1007/s10157-012-0641-3
Source: PubMed


Elevated heart rate (HR) is an independent risk factor for all-cause death or cardiovascular events in non-hemodialysis subjects; however, the clinical significance of elevated HR in hemodialysis patients is not well studied.
We prospectively evaluated the relationship between HR and adverse outcome in a total of 229 ambulatory hemodialysis patients (57 % men; mean age 62.2 years) recruited from two dialysis clinics in 2009. Mean (SD) HR of this cohort was 74.1 (11.0) beats per minute (bpm).
Receiver operating characteristic curves identified an HR cut-off level of ≥80 bpm for increased adverse outcome. After a mean follow-up of 525 days (range 7–760 days) a total of 30 primary endpoints (21 all-cause deaths, 4 acute coronary syndromes and 8 strokes) and 38 secondary endpoints (30 primary endpoints, 8 congestive heart failures, and 5 other cardiovascular events) were detected. Cox regression analysis revealed that HR >80 bpm was not an independent predictor of primary endpoints [hazard ratio 1.81, 95 % confidence interval (CI) 0.79–4.11, p = NS], but of secondary endpoints (hazard ratio 2.01, 95 % CI 1.01–4.22, p < 0.05) after adjusting for age, sex, hemodialysis duration, and cardiovascular risks.
Elevated HR is an independent predictor of all-cause death and cardiovascular events in Japanese ambulatory hemodialysis patients.

Download full-text


Available from: Taku Inoue
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiologic evidence indicates that an elevated heart rate (HR) is an independent predictor of all-cause and cardiovascular (CV) mortality. Ivabradine, a pure HR-lowering agent, reduces CV events in patients with coronary artery disease (CAD) and chronic heart failure, and indicate that an HR greater than 70 b.p.m. is hazardous. These findings demonstrate not only that an elevated HR is an epiphenomenon of CV risk status but also that an elevated HR itself should be a therapeutic target. In addition, recent epidemiologic evidence demonstrates that the in-treatment HR or HR change predicts subsequent all-cause and CV mortality, independent of the HR-lowering strategy. Characteristics of the in-treatment HR or HR change are also important as possible therapeutic guides for risk management. However, there have been concerns regarding deleterious effects on CV event prevention owing to β-blocker-derived pharmacologic HR reduction. The potential role of HR and its modulation should be considered in future guidance documents.Hypertension Research advance online publication, 22 August 2013; doi:10.1038/hr.2013.98.
    Full-text · Article · Aug 2013 · Hypertension Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Although a higher heart rate is known to be a risk factor for cardiovascular disease (CVD) events, there have been no reports concerning bradycardia. Whether lower and higher resting pulse rates (RPRs) are associated with cardiovascular risk was investigated in subjects from a community-based, prospective cohort study. Methods: After subjects with atrial fibrillation, subjects with a history of CVD, and subjects receiving antihypertensive treatment were excluded, 17,766 subjects (5958 men), aged 40-79 (mean 61.5) years, were analyzed. The RPR at baseline was categorized into four groups (RPR<60, 60-69.5, 70-79.5, ≥80 beats per minute (bpm)) using the average value of two consecutive measurements. The endpoint was set as the composite outcome of myocardial infarction, stroke, or sudden death. Results: During a mean follow-up of 5.6 years, there were 213 events in men and 186 events in women. In Cox regression models, increased risks of CVD were found in the men group with RPR<60 bpm, as well as the group with RPR≥80 bpm, compared with the reference group with RPR 60-69.5 bpm (hazard ratio [HR] = 1.73, p = 0.005 and HR = 2.01, p < 0.001). These increased risks were found even when adjusted for age and other CVD risk factors (HR = 1.55, p = 0.026 with RPR<60 bpm and HR = 1.72, p = 0.009 with RPR≥80 bpm). In women, there were no significant associations between RPR and CVD risk. Conclusion: Bradycardia, as well as a higher pulse rate, may be an independent risk factor for future cardiovascular events in apparently healthy men.
    No preview · Article · Jul 2014 · Atherosclerosis
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To explore the effect of high resting heart rate (RHR) on the stability of carotid artery plaque in a middle and advanced aged population. Methods: During 2010-2011, a total of 5 852 participants were selected randomly from 101 510 workers of a Tangshan Kailuan company. RHR was measured and carotid artery ultrasound performed to detect the carotid artery plaque. Logistic regression was performed to analyze the influencing factors of carotid artery stable and unstable plaque. Results: There were 4 894 subjects aged 40-95 years, including 2 945 males and 1 949 females. The detection rates of carotid artery stable and unstable plaque were 25.7% and 25.4% in low RHR group versus 23.8% and 33.2% in high RHR group. Compared with low RHR group, the risk of carotid artery unstable plaque increased to 29% in high RHR group after adjusting for all influencing factors. The odds ratio was 1.290 (95% CI 1.039-1.062). Conclusion: High RHR can increase the risk of carotid artery unstable plaque in middle and advanced aged population.
    No preview · Article · Aug 2014 · Zhonghua yi xue za zhi
Show more